Dutasteride: Clinical Trials

14 trials of Dutasteride, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed. 14 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 414Completed 14

Follow Dutasteride: new trials by email Literature Review of Dutasteride trials Research Report on Dutasteride

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prospective Sexual Function Study for BPH Subjects
Dutasteride plus tamsulosin, Placebo - Prostatic Hyperplasia
Phase 4CompletedGlaxoSmithKline4892013-02-182018-08-20
Dutasteride Treatment for the Reduction of Heavy Drinking in Men
Dutasteride, sugar pill - Alcoholism, Alcohol Abuse
Phase 4CompletedUConn Health1892013-01-012019-04-26
Dutasteride for the Reduction of Alcohol Use in Male Drinkers
Dutasteride, Placebo - Alcoholism, Alcohol Abuse
Phase 4CompletedUConn Health472011-01-012017-03-20
Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement
Dutasteride plus tamsulosin, tamsulosin - Prostatic Hyperplasia
Phase 4CompletedGlaxoSmithKline7422010-12-222018-08-20
Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation
avodart, Placebo - Prostate Cancer
Phase 4CompletedBay State Clinical Trials, Inc.402009-01-012014-05-14
Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement
dutasteride, placebo - Hypogonadism
Phase 4CompletedThe Miriam Hospital242008-09-012013-02-26
Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate
dutasteride - Benign Prostatic Hyperplasia
Phase 4CompletedSeoul National University Hospital402008-01-012013-06-12
Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy
dutasteride, placebo, bicalutamide - Neoplasms, Prostate
Phase 4CompletedGlaxoSmithKline1272007-05-012017-02-27
Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men
Dutasteride, Matching placebo - Neoplasms, Prostate
Phase 4CompletedGlaxoSmithKline3022006-07-012017-01-18
Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction
Dutasteride - Benign Prostatic Hyperplasia
Phase 4CompletedSamsung Medical Center362006-06-012009-06-11
Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer
Dutasteride - Benign Prostatic Hyperplasia, Prostate Cancer
Phase 4CompletedGlaxoSmithKline402005-04-012017-01-19
TRADE-Testosterone Replacement and Dutasteride Effectiveness
Dutasteride, Testosterone gel, Placebo dutasteride - Hypogonadism, Benign Prostatic Hyperplasia
Phase 4CompletedUniversity of Washington532005-03-012017-12-05
Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels
Dutasteride - Prostatic Hyperplasia
Phase 4CompletedGlaxoSmithKline502003-10-012016-09-15
The Role of 5-alpha Reductase in Mediating Testosterone Actions
Testosterone Enanthate, Dutasteride - Healthy
Phase 4CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1842002-11-012010-05-13

Conditions studied

Prostatic Hyperplasia (7)  ·  Prostatic Neoplasms (4)  ·  Alcoholism (2)  ·  Hypogonadism (2)  ·  Multiple Endocrine Neoplasia Type 1 (1)  ·  Neoplasms (1)

Sponsors

GlaxoSmithKline (6)  ·  UConn Health (2)  ·  Bay State Clinical Trials, Inc. (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Samsung Medical Center (1)  ·  Seoul National University Hospital (1)  ·  The Miriam Hospital (1)  ·  University of Washington (1)

Countries

United States (9)  ·  Netherlands (3)  ·  Canada (2)  ·  France (2)  ·  Germany (2)  ·  Greece (2)  ·  Spain (2)  ·  Australia (1)  ·  Hungary (1)  ·  Italy (1)  ·  Romania (1)  ·  South Korea (1)  ·  United Kingdom (1)

Top investigators

Abraham Morgentaler, MD (1)  ·  Alvin M Matsumoto, MD (1)  ·  Henry D Mitcheson, MD (1)  ·  Jonathan Covault, M.D., PhD. (1)  ·  Jonathan Covault, MD, PhD (1)  ·  Kyu-Sung Lee, Ph.D (1)  ·  Martin M Miner, MD (1)  ·  Shalender Bhasin, MD (1)

Results publications

PMID 21575967, PMID 22396515, PMID 25988518, PMID 29044968, PMID 29280355, PMID 38684046

NIH funding

P60AA003510 (2), R01HD043348 (1)